Latest California Healthline Stories
The good news: Life expectancy for people who make it to 65 has increased. Yet, coastal and urban people fare better than those in rural and middle America.
Because seniors are at higher risk of cognitive impairment, proponents say screening asymptomatic older adults is an important strategy to identify people who may be developing dementia and to improve their care. But the U.S. Preventive Services Task Force cited insufficient evidence the tests are helpful.
Nearly a decade ago, Dr. Jeffrey Brenner and his Camden Coalition appeared to have an answer to remake American health care: Treat the sickest and most expensive patients. But a rigorous study in the New England Journal of Medicine shows the approach doesn’t save money. “We built a brilliant intervention to navigate people to nowhere,” Brenner tells the “Tradeoffs” podcast.
As happens when the tech industry gets involved, hype surrounds the claims that artificial intelligence will help patients and even replace some doctors.
More than a decade after Congress passed a law mandating equal access for mental and physical health care, Americans struggle to find affordable, in-network mental health providers.
A federal audit of 19 California nursing homes released today found hundreds of violations of safety and emergency standards, putting vulnerable nursing home residents at increased risk of injury or death during a wildfire or other disaster.
Ilona Jaspers, an inhalation toxicologist at the University of North Carolina at Chapel Hill, believes the common notion of comparing e-cigarettes with traditional, combustible cigarettes is the wrong analogy because the vaping products expose consumers to chemicals in a fundamentally different way.
Warren’s claim on health insurance and bankruptcy is narrow enough to hold up.
Pharmaceutical companies raised the wholesale cost of their drugs by a median of nearly 26% from 2017 to early 2019, according to California’s first-ever report stemming from a new drug price transparency law. Prices for generic drugs rose nearly 38% during that time.
The reasons behind one particular shortage of a therapy known as IVIG are complicated, stemming from increased demand and the medication’s long production window.